Design and statistical optimization of osmotically driven capsule based on push-pull technology

References

• Prescott LF. (1989). The need for improved drug delivery in clinical practice. In: Novel Drug Delivery and its Therapeutic Application. West Susset, U.K.: John Wiley and Sons, 1–11.
   Google Scholar
• Makhija SN, Vavia PR. Controlled porosity osmotic pump-based controlled release systems of pseudoephedrine. I. Cellulose acetate as a semipermeable membrane. J Control Release 2003;89:5–18.
   PubMed Web of Science ®Google Scholar
• Theeuwes F. Elementary osmotic pump. J Pharm Sci 1975;64:1987–1991.
   PubMed Web of Science ®Google Scholar
• Gupta S, Singh RP, Sharma R, Kalyanwat R, Lokwani P. Osmotic pumps: a review. Int J Comp Pharm 2011;2:1–8.
   Google Scholar
• Santus G, Baker RW. Osmotic drug delivery: a review of the patent literature. J Control Release 1995;35:1–21.
   Web of Science ®Google Scholar
• Prabakaran D, Singh P, Kanaujia P, Jaganathan KS, Rawat A, Vyas SP. Modified push-pull osmotic system for simultaneous delivery of theophylline and salbutamol: development and in vitro characterization. Int J Pharm 2004;284:95–108.
   PubMed Web of Science ®Google Scholar
• Liu L, Ku J, Khang G, Lee B, Rhee JM, Lee HB. Nifedipine controlled delivery by sandwiched osmotic tablet system. J Control Release 2000;68:145–156.
   PubMed Web of Science ®Google Scholar
• Wong PSL, Barclay BL, Deters JC, Theeuwes F. Osmotic device for administering certain drugs. US Patent 4765989; 1986:1–65.
   Google Scholar
• Waterman KC, Goeken GS, Konagurthu S, Likar MD, MacDonald BC, Mahajan N et al. Osmotic capsules: A universal oral, controlled-release drug delivery dosage form. J Control Release 2011;152:264–269.
   PubMed Web of Science ®Google Scholar
• Thombre AG, Cardinal JR, DeNoto AR, Gibbes DC. Asymmetric membrane capsules for osmotic drug delivery II. In vitro and in vivo drug release performance. J Control Release 1999;57:65–73.
   PubMed Web of Science ®Google Scholar
• Thombre AG, Cardinal JR, DeNoto AR, Herbig SM, Smith KL. Asymmetric membrane capsules for osmotic drug delivery. I. Development of a manufacturing process. J Control Release 1999;57:55–64.
   PubMed Web of Science ®Google Scholar
• Herbig SM, Cardinal JR, Korsmeyer RW, Smith KL. Asymmetric-membrane tablet coatings for osmotic drug delivery. J Controlled Release 1995;35:127–136.
   Web of Science ®Google Scholar
• Barzegar-Jalali M, Adibkia K, Mohammadi G, Zeraati M, Bolagh BA, Nokhodchi A. Propranolol hydrochloride osmotic capsule with controlled onset of release. Drug Deliv 2007;14:461–468.
   PubMed Web of Science ®Google Scholar
• Choudhury PK, Ranawat MS, Pillai MK, Chauhan CS. Asymmetric membrane capsule for osmotic delivery of flurbiprofen. Acta Pharm 2007;57:343–350.
   PubMedGoogle Scholar
• Philip A, Pathak K. In situ-formed asymmetric membrane capsule for osmotic release of poorly water-soluble drug. PDA J Pharm Sci Technol 2007;61:24–36.
   PubMedGoogle Scholar
• Wang CY, Ho HO, Lin LH, Lin YK, Sheu MT. Asymmetric membrane capsules for delivery of poorly water-soluble drugs by osmotic effects. Int J Pharm 2005;297:89–97.
   PubMed Web of Science ®Google Scholar
• Malaterre V, Ogorka J, Loggia N, Gurny R. Approach to design push-pull osmotic pumps. Int J Pharm 2009;376:56–62.
   PubMed Web of Science ®Google Scholar
• Malaterre V, Ogorka J, Loggia N, Gurny R. Evaluation of the tablet core factors influencing the release kinetics and the loadability of push-pull osmotic systems. Drug Dev Ind Pharm 2009;35:433–439.
   PubMed Web of Science ®Google Scholar
• Gupta V, Verma S, Nanda A, Nanda S. Osmotically controlled drug delivery: Review. Drug Del Technol 2005;5:68–76.
   Google Scholar
• Gurrapu A, Jukanti R, Bobbala SR, Kanuganti S, Jeevana JB. Improved oral delivery of valsartan from maltodextrin based proniosome powders. Adv Powder Technol 2011;23:583–590.
   Web of Science ®Google Scholar
• Brookman LJ, Rolan PE, Benjamin IS, Palmer KR, Wyld PJ, Lloyd P et al. Pharmacokinetics of valsartan in patients with liver disease. Clin Pharmacol Ther 1997;62:272–278.
   PubMed Web of Science ®Google Scholar
• Mehtap S, Sevgi T. Bioavailability file: Valsartan. FABAD J Pharm Sci 2007;32:185–196.
   Google Scholar
• Prabakaran D, Singh P, Kanaujia P, Vyas SP. Effect of hydrophilic polymers on the release of diltiazem hydrochloride from elementary osmotic pumps. Int J Pharm 2003;259:173–179.
   PubMedGoogle Scholar
• Najib N, Suleiman MS. The kinetics of drug release from ethyl cellulose solid dispersions. Drug Dev Ind Pharm 1985;11:2169–2181.
   Web of Science ®Google Scholar
• Desai SJ, Singh P, Simonelli AP, Higuchi WI. Investigation of factors influencing release of solid drug dispersed in inert matrices. 3. Quantitative studies involving the polyethylene plastic matrix. J Pharm Sci 1966;55:1230–1234.
   PubMed Web of Science ®Google Scholar
• Higuchi T. Mechanism of sustained-action medication. theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 1963;52:1145–1149.
   PubMed Web of Science ®Google Scholar
• Hixson AW, Crowell JH. Dependence of reaction velocity upon surface and agitation (I) theoretical consideration. Ind Eng Chem 1931;23:923–931.
   Google Scholar
• Korsenmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. Mechanism of solute release from porous hydrophilic polymers. Int J Pharm 1983;15:25–35.
   Google Scholar
• Singhvi G, Singh M. In-vitro drug release characterization models: review. Int J Pharm Stud Res 2011;2:77–84.
   Google Scholar